More consistent dose delivery was achieved with the breath actuated technology rather than breath enhanced.
Delivering medication only when the patient inhales would result in more stable therapy if I:E ratio was to change with disease< progression or if the patient took breaks to talk during treatment.
Manage asthma during wildfires by monitoring air quality, indoor cleanliness, limiting outdoor exposure, wearing masks, consulting healthcare providers, and optimizing medication with AeroChamber VHC* and AeroChamber 2Go*.
Manage asthma during wildfires by monitoring air quality, indoor cleanliness, limiting outdoor exposure, wearing masks, consulting healthcare providers, and optimizing medication with AeroChamber VHC* and AeroChamber 2Go*.
Join Dr. Sacha Bhinder, HBSc, MD, FRCPC, for a review of inhaled delivery device products that are available in Canada, and how to foster customized care when choosing the most appropriate device for your patient.
Join Professor Omar Usmani and Dr. John Pritchard as they review the environmental impact of inhaled medications. Tune in to discover how to develop patient centric strategies to reduce the impact of inhalers on the climate.
This conversation will cover:
Climate change and carbon impact of pressurised Metered Dose Inhalers (pMDIs)
Join Dr. Douglas Mack and Dr. Mariam Hanna as they discuss the importance of asthma control in today’s world, as well as the shift to virtual appointments including tools and tips to optimize virtual asthma assessments. Please see a recording of the session below.
Join Dr. Michael Mitar for a discussion surrounding the care of COPD patients in 2022 and overcoming obstacles in the treatment pathway presented through COVID.
By watching this webinar, you will learn about:
✓ Updated COPD guidelines
✓ New options in medications
✓ Non pharmacotherapeutic treatment options
✓ Spirometry access
Enter your information below to watch a recording of the webinar:
If you or someone in your family has asthma and is going away on vacation, it is important to create a checklist to ensure that the necessary research has been done and all of the necessary items are brought with you to your destination!
A systematic review of nebulizer use highlighted a few different potential mechanisms for fugitive emissions. Differences in nebulizer design had an impact in the amount and type of fugitive emissions emitted.
Through the choice of an appropriate nebulizer, the natural risk can be greatly reduced, and through selection of appropriate mitigation strategies, the risk can be almost eliminated.
Accelerate and scale your digital Metered Dose Inhaler (MDI) portfolio programs with the trusted Top Mounted Actuation Indicator (TMAI) technology platform.
The delivery of medication from the AEROECLIPSE* II BAN* to the lungs was not affected by the incorporation of the Aerobika* OPEP device. Aerosol deposition within the lung was unaltered by the addition of the OPEP device as evidenced by the near identical percentage of the dose being deposited in both the peripheral and central airways.
BAN+OPEP therapy could offer the clinician the opportunity for combined treatment thereby reducing the time needed for the patient to take both nebulizer and OPEP treatments separately.
A systematic review of nebulizer use highlighted a few different potential mechanisms for fugitive emissions. Differences in nebulizer design had an impact in the amount and type of fugitive emissions emitted.
Through the choice of an appropriate nebulizer, the natural risk can be greatly reduced, and through selection of appropriate mitigation strategies, the risk can be almost eliminated.
If you or someone in your family has asthma and is going away on vacation, it is important to create a checklist to ensure that the necessary research has been done and all of the necessary items are brought with you to your destination!
The first day of school is less than a month away! This can be a busy and exciting time for you and your children. However, if your child suffers from asthma it is also a good time to take steps to protect them from the “September Spike”.
This article describes the generative, patient-centered, design process used in the development of a prototype VHC intended primarily for use ‘on the go’ by adults with persistent asthma or newly diagnosed COPD.
